Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Moderna a Bad-News Buy?

TheMotleyFool

0 0

We've gotten used to revenue increases from Moderna (NASDAQ: MRNA), so the most recent earnings report may have felt to investors like a bucket of ice water thrown over their heads. The coronavirus vaccine maker posted a 35% drop in third-quarter product sales. And profit fell a whopping 68%.

The company also recorded a charge for inventory write-downs, linked to coronavirus vaccines that went unused.

Does this news mean that demand is falling and it may be time to walk away from Moderna? Or is the stock actually a bad-news buy? Let's find out.

Source Fool.com

Like: 0

MRNA

Teilen